Agomab
Unlocking Disease Modification in Fibro-Inflammation
78 employees · est. 2017 · Ghent, Belgium
XVIVO Abdominal
We believe in an extended life of organs. Nobody should die waiting for a new organ.
11 employees · est. 2005 · Groningen, The Netherlands
XVIVO Abdominal is the older company (2017 vs 2005); Agomab is the larger of the two.
Side-by-Side Comparison
| Metric | Agomab | XVIVO Abdominal |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2005 older |
| Headquarters | ||
| Headquarters | Ghent, Belgium | Groningen, The Netherlands |
| Employees | ||
| Employees | 78 larger | 11 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Health Care |
| Funding Stage | ||
| Funding Stage | Series D | Series Unknown |
| Total Funding | ||
| Total Funding | $310.40M | $1.70M |
| Funding Rounds | ||
| Funding Rounds | 5 | 2 |
| Services | ||
| Services | Development of novel disease-modifying therapies, Clinical trials for fibrosis and inflammatory diseases, Research in growth factor biology | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with fibrotic diseases, Healthcare professionals in immunology and inflammatory diseases, Investors interested in biopharmaceutical innovations | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Drug Development, Growth Factor Biology, Fibrosis Treatment, Tissue Repair, Organ Function Restoration, Clinical Pipeline, Disease Modification, Severe Organ Failure, Fibrotic Diseases, Pharmaceuticals, Innovation, Scientific Insights, Long-term Vision, Differentiated Programs | Organ Preservation, Oxygenated Machine Perfusion, Organ Transplant, Donor Organs, Organ Perfusion Systems, Organ Transportation, Liver Perfusion, Kidney Perfusion, Lung Perfusion, Medical Training, Organ Preservation Technology, NRP (Normothermic Regional Perfusion), Organ Assist Devices |
| Website | ||
| Website | agomab.com | organ-assist.nl |
About Agomab
Agomab is emerging as a significant player in the Biotechnology sector, established in 2017 and headquartered in Belgium. The company leverages its deep expertise in growth factor biology to innovate treatments aimed at resolving fibrosis, repairing tissue structures, and restoring organ functionali...
About XVIVO Abdominal
XVIVO Abdominal is a company dedicated to extending the life of organs and eliminating the need for individuals to die while awaiting a transplant. Founded in 2005 and based in The Netherlands, the company's flagship product is Organ Assist, which utilizes oxygenated machine perfusion to enhance the...
We will tell you when either one moves
BounceWatch watches Agomab and XVIVO Abdominal for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Agomab and XVIVO Abdominal — by email.
Frequently Asked Questions
Compare Agomab with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Agomab on 12 Apr 2026, and XVIVO Abdominal on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
